Skip navigation
logo
(AFX UK Focus) 2008-12-29 22:47
BRIEF-Watson Pharmaceuticals gets FDA nod for generic Mircette
Article layout: reformatted
Dec 29 (Reuters) - Watson Pharmaceuticals Inc: 

* Receives FDA final approval for generic Mircette 

* Says intends to launch the product in early January 2009 under the trade name 
      Azurette 

((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) 
     
(For more news, please click here)

COPYRIGHT

Copyright Thomson Reuters 2008. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
General news
Government regulatory actions
Article layout: reformatted
Jump back to site navigation